Q2i, King’s College London, and UK Government Join Forces to Revolutionize Prisoner Reintegration with AI

BOSTON, Feb. 24, 2025 /PRNewswire/ — Q2i, a leader in digital innovation, has announced that its contingency management division (CMI) has joined forces with the UK Government and King’s College London (King’s) to develop an advanced AI-powered platform aimed at revolutionizing the rehabilitation and reintegration process for individuals transitioning from the prison system back into society.

This partnership addresses the critical challenge of improving addiction treatment continuity and reducing reoffending rates by providing data-driven, personalized support tailored to meet the diverse needs of individuals leaving prison.

Professor Mike Lewis, Scientific Director for Innovation at the National Institute for Health and Care Research (NIHR), emphasized the need for innovative approaches: “Innovation in managing addiction is needed to break the pattern of prison relapse and rebound and the wider impacts of addiction on society. Interventions, including AI, that allow management in the community need this research to validate their potential so we can implement them at scale.”

The AI platform integrates advanced analytics with a user-friendly, human-centric design, offering an accessible and engaging experience. It empowers individuals with customized resources and real-time support to navigate their transition effectively. By leveraging Q2i’s cutting-edge AI technology, the platform connects users with essential healthcare resources, employment opportunities, housing solutions, and educational programs. This holistic approach empowers former prisoners to successfully reintegrate into society and lead productive lives. 

Professor Sir John Strang, leading the King’s team, emphasized the collaboration’s significance: “This initiative showcases the transformative potential of AI in criminal justice reform. By equipping individuals leaving prison with the appropriate tools and resources, we aim to enhance their chances of successful reintegration and long-term positive outcomes.”

Steven Jenkins, CEO of Q2i, added: “At Q2i, we believe in technology’s power to drive real-world impact and positive change. Our partnership with King’s and the UK Government demonstrates how AI can tackle complex societal challenges. Our platform empowers individuals to rebuild their lives, reduce reoffending, and successfully reenter society.”

For further information on Q2i, visit Q2i.

About Q2i
Q2i is a privately held digital health company specializing in the development, refinement, validation, and commercialization of evidence-based, innovative solutions. Our AI-driven contextual agent technology is leading the way in transforming how community supervision is managed, supported, and optimized for success.

View original content to download multimedia:https://www.prnewswire.com/news-releases/q2i-kings-college-london-and-uk-government-join-forces-to-revolutionize-prisoner-reintegration-with-ai-302383708.html

SOURCE Q2I

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

16 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

16 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

16 hours ago